OppenheimerFunds’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$3.56M Buy
275,035
+50,809
+23% +$890K ﹤0.01% 798
2018
Q4
$3.38M Buy
224,226
+110,592
+97% +$2.86M ﹤0.01% 791
2018
Q3
$4.47M Buy
+113,634
New +$5.12M 0.01% 799
2017
Q2
Sell
-589,087
Closed -$42.8M 1857
2017
Q1
$42.8M Sell
589,087
-218,955
-27% -$14.4M 0.05% 348
2016
Q4
$47.4M Buy
+808,042
New +$42.7M 0.06% 323

Other funds holding ADNT

OppenheimerFunds's ADNT Position: Q1 2019 in Review

OppenheimerFunds increased its Adient (ADNT) stake by 23% in Q1 2019, buying an estimated $890K and bringing the position to 275,035 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #798.

OppenheimerFunds first reported a position in ADNT in Q4 2016 and has held it in 5 quarters since. The position peaked at $47.4M in Q4 2016. 352 funds tracked by Wall St. Rank hold ADNT as of Q1 2019.

  • OppenheimerFunds held 275,035 shares of Adient worth $3.56M as of Q1 2019.
  • OppenheimerFunds bought 50,809 Adient shares in Q1 2019, an estimated $890K.
  • Adient made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #798 holding.
  • OppenheimerFunds first reported a position in Adient in Q4 2016 and has held it in 5 quarters since.
  • OppenheimerFunds's Adient position peaked at $47.4M in Q4 2016.
  • 352 funds tracked by Wall St. Rank held Adient as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.